Malignant lymphomas, including Hodgkin’s disease: Diagnosis, management, and special problems

  • Bruce W. Dana
Part of the Cancer Treatment and Research book series (CTAR, volume 66)

Table of contents

  1. Front Matter
    Pages i-x
  2. R. Dean Butler, John D. Hainsworth
    Pages 65-79
  3. Vincent J. Picozzi Jr.
    Pages 81-94
  4. Mary Kay Gumerlock, Edward A. Neuwelt
    Pages 111-126
  5. Oliver W. Press, Janet Eary, Frederick R. Appelbaum, Christopher C. Badger, Irwin D. Bernstein
    Pages 127-145
  6. Rita M. Braziel, Allan R. Sacker
    Pages 147-165
  7. Back Matter
    Pages 167-174

About this book

Introduction

This volume is intended to present an eclectic selection of informative reviews on aspects of the malignant lymphomas, including Hodgkin's disease. The choice of suitable review topics in this field is made hazardous by several facts. First, the growth of insight into basic mechanisms of lymphomagenesis is explosive, as is the expansion of our understanding of the need for precise morphologic classification of these diseases. Second, new therapeutic agents, cytotoxic and biologic, as well as new drug delivery strategies, are appearing with remarkable frequency. Finally, old "standard" approaches, such as the staging laparotomy for Hodgkin's disease, are being reconsidered and deserve attention in an up-to-date collection of papers. The 10 reviews presented here fall generally into three categories. First, the optimal diagnostic and therapeutic approaches to Hodgkin's disease are considered by Mark Leibenhaut, who reviews the status of the diagnostic staging laparotomy, and by Philip Bierman, who discusses his thoughts on the timing of high-dose treatment with bone marrow transplantation for this disease. There follow four reviews of current management of specific histologic subtypes of malignant lymphoma. First, Velasquez reviews prognostic factors in both intermediate and high grade lymphomas. Miller and Dahlberg review and update the Southwest Oncology Group experience in developing curative cytotoxic combination therapies for diffuse large-cell lymphomas. Lastly, optimal therapy for two kinds of high grade lymphoma are presented. Butler and Hainsworth describe the Vanderbilt experience with diffuse small noncleaved cell lymphoma and Picozzi reviews lymphoblastic lymphoma.

Keywords

Staging cell lymphoma oncology transplantation

Editors and affiliations

  • Bruce W. Dana
    • 1
    • 2
  1. 1.Oregon Health Sciences UniversityUSA
  2. 2.The Hematology Clinic PortlandUSA

Bibliographic information

  • DOI https://doi.org/10.1007/978-1-4615-3084-8
  • Copyright Information Kluwer Academic Publishers 1993
  • Publisher Name Springer, Boston, MA
  • eBook Packages Springer Book Archive
  • Print ISBN 978-1-4613-6347-7
  • Online ISBN 978-1-4615-3084-8
  • Series Print ISSN 0927-3042
  • About this book